Literature DB >> 11765822

Recovery from complete hemiplegia following resection of a retrocentral metastasis: the prognostic value of intraoperative cortical stimulation.

H Duffau1.   

Abstract

The goal in this study was to determine if intraoperative electrical stimulation mapping is useful during surgical resection of lesions located in the central region, even in cases of preoperative hemiplegia. This 45-year-old man with a retrocentral metastasis from an embryonal carcinoma of the testis suffered an acute complete hemiplegia after intratumoral bleeding. Emergency surgery was performed with the aid of intraoperative motor mapping despite the preoperative deficit. Cortical stimulations (CSs) elicited motor responses, allowing the detection and hence preservation of the primary motor area during tumor removal. Postoperatively, the patient recovered almost completely within 1 week; the tumor resection was total. It is possible that CSs give an early and valuable prognostic indicator of motor recovery in cases of complete hemiplegia, at least in patients with acute onset and short duration of the deficit. Consequently, if motor responses can be elicited by CSs, it becomes mandatory for the surgeon to respect the primary motor area despite the preoperative hemiplegia, with the aim of preserving the chances of an eventual recovery.

Entities:  

Mesh:

Year:  2001        PMID: 11765822     DOI: 10.3171/jns.2001.95.6.1050

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Surgery on motor area metastasis.

Authors:  Marta Rossetto; Pietro Ciccarino; Giuseppe Lombardi; Giuseppe Rolma; Diego Cecchin; Alessandro Della Puppa
Journal:  Neurosurg Rev       Date:  2015-07-17       Impact factor: 3.042

2.  The corticotegmental connectivity as an integral component of the descending extrapyramidal pathway: novel and direct structural evidence stemming from focused fiber dissections.

Authors:  Spyridon Komaitis; Faidon Liakos; Aristotelis V Kalyvas; Evangelos Drosos; Georgios P Skandalakis; Eleftherios Neromyliotis; Apostolos Gerogiannis; Theodore Troupis; George Stranjalis; Christos Koutsarnakis
Journal:  Neurosurg Rev       Date:  2021-02-10       Impact factor: 3.042

Review 3.  New concepts in surgery of WHO grade II gliomas: functional brain mapping, connectionism and plasticity--a review.

Authors:  Hugues Duffau
Journal:  J Neurooncol       Date:  2006-04-11       Impact factor: 4.130

4.  Clinical significance of preoperative fibre-tracking to preserve the affected pyramidal tracts during resection of brain tumours in patients with preoperative motor weakness.

Authors:  Nobuhiro Mikuni; Tsutomu Okada; Rei Enatsu; Yukio Miki; Shin-ichi Urayama; Jun A Takahashi; Kazuhiko Nozaki; Hidenao Fukuyama; Nobuo Hashimoto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-01       Impact factor: 10.154

5.  Intraoperative electrical stimulation mapping as an aid for surgery of intracranial lesions involving motor areas in children.

Authors:  Francesco Signorelli; J Guyotat; C Mottolese; F Schneider; G D'Acunzi; J Isnard
Journal:  Childs Nerv Syst       Date:  2004-05-07       Impact factor: 1.475

Review 6.  Awake surgery for hemispheric low-grade gliomas: oncological, functional and methodological differences between pediatric and adult populations.

Authors:  Gianluca Trevisi; Thomas Roujeau; Hugues Duffau
Journal:  Childs Nerv Syst       Date:  2016-09-20       Impact factor: 1.475

Review 7.  Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics.

Authors:  Artemiy S Silantyev; Luca Falzone; Massimo Libra; Olga I Gurina; Karina Sh Kardashova; Taxiarchis K Nikolouzakis; Alexander E Nosyrev; Christopher W Sutton; Panayiotis D. Mitsias; Aristides Tsatsakis
Journal:  Cells       Date:  2019-08-09       Impact factor: 6.600

8.  Selective excision of cerebral metastases from the precentral gyrus.

Authors:  Robert G Kellogg; Lorenzo F Munoz
Journal:  Surg Neurol Int       Date:  2013-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.